Loading: 100%
UTAH MEDICAL PRODUCTS INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees (as per )no data available
Sector Medical Instruments & Equipmen, HealthcareMedical Instruments & Equipmen, Healthcareno data available
Ticker UTMDno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 175460667278
datesClosing price (adj.)
13.10.201775.30
11.10.201777.10
04.10.201775.00
27.09.201773.95
20.09.201772.40
13.09.201773.38
06.09.201773.43
30.08.201770.59
23.08.201770.15
16.08.201771.34
09.08.201772.39
02.08.201768.55
26.07.201770.59
19.07.201772.19
12.07.201771.64
05.07.201771.94
27.06.201771.44
20.06.201771.89
13.06.201769.19
06.06.201769.88
30.05.201765.81
23.05.201764.47
16.05.201763.73
09.05.201762.93
02.05.201762.04
25.04.201761.94
18.04.201761.79
11.04.201761.05
04.04.201760.50
28.03.201760.75
21.03.201760.60
14.03.201760.39
07.03.201759.55
28.02.201761.18
21.02.201761.13
14.02.201760.19
07.02.201760.59
31.01.201761.48
24.01.201762.71
17.01.201765.88
10.01.201768.94
03.01.201770.57
27.12.201669.24
19.12.201667.26
12.12.201667.94
05.12.201667.94
28.11.201666.95
21.11.201665.47
14.11.201665.97
07.11.201658.38
31.10.201661.19
24.10.201662.08
17.10.201659.86
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
75.30n/a
Market Capitalisation
in million USD
280n/a
Enterprise Value
in million USD
246n/a
Common Shares Outstanding
as per Aug 2, 2017
3,719,026n/a
Preferred Shares Outstanding
as per Aug 2, 2017
n/a
Average Basic Shares Outstanding
TTM
3,730,750n/a
Average Diluted Shares Outstanding
TTM
3,745,500n/a
Index Membership
n/a
Business Summary
Utah Medical Products Inc is in the business of producing medical devices that are predominantly proprietary, disposable and for hospital use.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 34n/a
Receivables 0n/a
Total Current Assets 44n/a
PP&E 10n/a
Total Assets 86n/a
Accounts Payable 1n/a
Current Debt 0n/a
Total Current Liabilities 4n/a
Long-Term Debt 0n/a
Total Liabilities 9n/a
Total Equity 77n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 20.71n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 3.64n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.28n/a
Other Ratios
Current Ratio 996.6%n/a
Liabilities to Equity Ratio 11.3%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 87% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
26
25
38
42
40
41
40
39
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-12
-12
-15
-16
-16
-16
-16
-16
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
14
13
22
25
24
25
24
24
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-3
-3
8
-7
-7
-7
-6
-6
Selling, General & Administrative
-2
-2
7
-7
-6
-6
-6
-5
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
0
0
1
-1
0
0
-1
0
Depreciation & Amortization
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
Operating Income (Loss)
11
10
30
18
18
18
18
18
Non-Operating Income (Loss)
0
0
-1
-1
0
0
0
0
Interest Expense, net
0
0
-1
-1
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
11
11
29
17
17
18
18
18
Abnormal Gains (Losses)
-2
-2
3
-3
-3
-2
-2
-2
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
10
9
32
14
14
16
15
16
Income Tax (Expense) Benefit, net
-3
-3
-4
-4
-3
-4
-4
-4
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
6
6
28
10
11
11
12
12
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
6
6
28
10
11
11
12
12
Minority Interest
0
0
0
0
0
0
0
0
Net Income
6
6
28
10
11
11
12
12
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
6
6
28
10
11
11
12
12
Remarks
restated on Oct 25, 2012 n/a
calculated values,
restated on Mar 7, 2013 n/a
calculated values,
restated on Mar 12, 2014 n/a
calculated values,
restated on Mar 12, 2015 n/a
calculated values,
restated on Mar 10, 2016 n/a
calculated values,
restated on Mar 8, 2017 n/a
calculated values,
restated on Mar 8, 2017 n/a
calculated values,
restated on Mar 8, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
19
7
9
14
19
23
26
Cash & Cash Equivalents
n/a
4
7
9
14
19
23
26
Short Term Investments
n/a
15
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
0
0
0
0
0
0
0
Accounts Receivable, Net
n/a
0
0
0
0
0
0
0
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
3
5
4
5
5
4
5
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
4
5
5
5
5
5
4
Prepaid Expenses
n/a
0
0
0
0
0
0
1
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
3
5
4
4
5
5
3
Total Current Assets
n/a
25
17
19
24
30
33
35
Property, Plant & Equipment, Net
n/a
9
9
8
8
8
7
10
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
7
51
50
48
43
39
32
Intangible Assets
n/a
0
0
0
0
0
0
0
Goodwill
n/a
7
15
15
16
15
15
13
Other Intangible Assets
n/a
0
35
34
32
28
24
18
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
0
0
0
0
0
Total Noncurrent Assets
n/a
16
59
58
56
51
46
42
Total Assets
n/a
41
76
77
81
81
79
77
Liabilities and owners' equity
Payables & Accruals
n/a
2 1688000
4 4201000
4 3821000
4 3559000
5 5077000
4 4066000
3 3022000
Accounts Payable
n/a
0 398000
1 925000
1 1000000
1 773000
1 929000
1 649000
1 906000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
1 1290000
3 3276000
3 2821000
3 2786000
4 4148000
3 3417000
2 2116000
Short Term Debt
n/a
0 215000
5 5430000
4 4001000
4 4052000
4 3894000
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
2 1903000
10 9631000
8 7822000
8 7611000
9 8971000
4 4066000
3 3022000
Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
2 1543000
26 26001000
18 18139000
13 12519000
8 7549000
5 5461000
4 4318000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
1 634000
9 9237000
9 8773000
7 7454000
7 6576000
5 5461000
4 4318000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
1 909000
17 16764000
9 9366000
5 5065000
1 973000
0 0
0 0
Total Noncurrent Liabilities
n/a
2 1543000
26 26001000
18 18139000
13 12519000
8 7549000
5 5461000
4 4318000
Total Liabilities
n/a
3 3446000
36 35632000
26 25961000
20 20130000
17 16520000
10 9527000
7 7340000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
0 143000
1 757000
2 2305000
3 3315000
3 2927000
3 2748000
0 415000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
39 38924000
43 42904000
50 49519000
57 57250000
65 64863000
73 72861000
81 81072000
Other Equity
n/a
-1 -1275000
-3 -2906000
-1 -851000
0 16000
-3 -3234000
-6 -5961000
-12 -12243000
Equity Before Minority Interest
n/a
38 37792000
41 40755000
51 50973000
61 60581000
65 64556000
70 69648000
69 69244000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
38 37792000
41 40755000
51 50973000
61 60581000
65 64556000
70 69648000
69 69244000
Total Liabilities & Equity
n/a
41 41238000
76 76387000
77 76934000
81 80711000
81 81076000
79 79175000
77 76584000
Remarks restated on n/a restated on Oct 25, 2012 n/a restated on Mar 7, 2013 n/a restated on Mar 12, 2014 n/a restated on Mar 12, 2015 n/a restated on Mar 10, 2016 n/a restated on Mar 8, 2017 n/a restated on Aug 3, 2017 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
7
7
10
14
15
15
15
15
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
0
0
0
0
0
0
0
0
Non-Cash Items
0
0
0
0
0
0
0
0
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
0
0
0
-1
-1
-1
-1
0
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
7
7
10
13
13
14
14
14
Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-6
7
-53
1
0
-2
-1
-6
Dividends Paid
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
0
0
0
0
0
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
0
0
0
0
0
0
Increase in Capital Stock
0
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
-8
-13
36
-23
-14
-17
-18
-12
Net Cash Before Disc. Operations and FX
-7
1
-7
-9
0
-5
-5
-3
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
-7
1
-7
-9
0
-5
-5
-3
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
Net Changes in Cash
-7
1
-7
-9
0
-5
-5
-3
Remarks
restated on Oct 25, 2012 n/a
calculated values,
restated on Mar 7, 2013 n/a
calculated values,
restated on Mar 12, 2014 n/a
calculated values,
restated on Mar 12, 2015 n/a
calculated values,
restated on Mar 10, 2016 n/a
calculated values,
restated on Mar 8, 2017 n/a
calculated values,
restated on Mar 8, 2017 n/a
calculated values,
restated on Mar 8, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo